The synergism of SMC1A cohesin gene silencing and bevacizumab against colorectal cancer.
Maddalena Di NardoSimonetta AstigianoSilvia BaldariMaria Michela PallottaGiovanni PortaSimona PigozziAnnalisa AntoniniLaura EmioniteAnnalisa FrattiniRoberto ValliGabriele ToiettaSilvia SodduAntonio MusioPublished in: Journal of experimental & clinical cancer research : CR (2024)
These results indicate that SMC1A silencing, in combination with bevacizumab, can represent a promising therapeutic strategy for human CRC.